Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 4.1M | 1.9M | 1.5M | 958,000 | 2.2M | 1.2M |
| Gross Profit | 2.3M | 740,000 | 413,000 | -18,000 | 1.4M | -639,000 |
| Profitability | ||||||
| Operating Income | -51.1M | -61.0M | -25.1M | -18.0M | -53.7M | -29.7M |
| EBITDA | -48.9M | -59.5M | -23.5M | -16.5M | -52.9M | -29.4M |
| Net Income | -50.2M | -60.7M | -27.8M | -72.9M | -64.1M | -29.9M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 30M | 13M | 8M | 6M | 92M | 69M |
Insight Molecular Diagnostics Inc. Income Statement — FAQ
Insight Molecular Diagnostics Inc. (IMDX) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMDX's income statement history?
The chart and table above show Insight Molecular Diagnostics Inc.'s income statement by year and by quarter, including the growth rate.